Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Daebong Ls Co. Ltd. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being reviewed by 1 distinct examiner, indicating a singular point of contact within the patent office for the company's current filings. The prosecution is localized within 1 distinct art unit, which focuses the technical review process on a specific area of biotechnology. This concentration allows the company to dedicate its resources to addressing the specific concerns of 1 distinct examiner, rather than managing a diverse array of office actions.
The busiest examiner identified is HA, JULIE, who is handling 1 busiest examiner pending action. Since this is the 1 busiest examiner pending action for the company, this examiner's specific approach to biotechnology claims will be the determining factor for the portfolio's immediate progress. The limited scope of 1 pending office action suggests a focused prosecution effort. By interacting with 1 distinct examiner, the company can better predict potential hurdles based on the past examination history of that 1 distinct examiner. This focused approach within 1 distinct art unit ensures that the company's legal strategy is aligned with the technical expectations of the patent office, moving the 1 pending office action toward a resolution.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HA, JULIE | 1 | 75.7% | +44.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| Art Unit | Apps |
|---|---|
| 1654 | 1 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial